Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Net Income (2022 - 2025)

Historic Net Income for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to -$5.1 million.

  • bioAffinity Technologies' Net Income fell 15244.82% to -$5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.7 million, marking a year-over-year decrease of 7450.88%. This contributed to the annual value of -$9.0 million for FY2024, which is 1389.47% down from last year.
  • Per bioAffinity Technologies' latest filing, its Net Income stood at -$5.1 million for Q3 2025, which was down 15244.82% from -$4.1 million recorded in Q2 2025.
  • bioAffinity Technologies' 5-year Net Income high stood at -$88052.0 for Q2 2022, and its period low was -$5.1 million during Q3 2025.
  • In the last 4 years, bioAffinity Technologies' Net Income had a median value of -$2.1 million in 2024 and averaged -$2.5 million.
  • Data for bioAffinity Technologies' Net Income shows a peak YoY increase of 5343.22% (in 2023) and a maximum YoY decrease of 187630.15% (in 2023) over the last 5 years.
  • bioAffinity Technologies' Net Income (Quarter) stood at -$1.7 million in 2022, then crashed by 41.72% to -$2.4 million in 2023, then decreased by 25.02% to -$3.0 million in 2024, then tumbled by 70.25% to -$5.1 million in 2025.
  • Its last three reported values are -$5.1 million in Q3 2025, -$4.1 million for Q2 2025, and -$2.7 million during Q1 2025.